TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Aphria Inc. Posts 47% EBITDA Growth in Q1 2018, Helped by Lower Costs
Investing
Are Marijuana Stocks Growing Too Fast?
Investing
Projecting Revenues for Canopy Growth Corp. for 2018
Investing
3 Reasons Canopy Growth Corp. and Aurora Cannabis Inc. Could Double in Value
Investing
3 Stocks to Invest in for Exposure to Cannabis
Investing
Aphria Inc. Posts Strong Q1 Results That Show Further Cost Reductions
Investing
3 Traits of a Successful Cannabis Growth Investor
Investing
Canopy Growth Corp. Stock to Soar Further After Announcing Another Exponential Growth Driver